Advances in Interventional Cardiology
eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2025
vol. 21
 
Share:
Share:
Original paper

Clinical features and prognosis in patients with coronary anomalies: the experiences and follow-up results of a single center

Emine Altuntaş
1
,
Iffet Doğan
2
,
Merve Yükselen Aydın
1
,
Aybüke Simsek
1
,
Aysel Türkvatan Cansever
2
,
Mehmet Ertürk
1

  1. Cardiology Clinic, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training Research Hospital, Istanbul, Turkey
  2. Radiology Clinic, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training Research Hospital, Istanbul, Turkey
Adv Interv Cardiol 2025; 21, 3 (81): 341–349
Online publish date: 2025/09/15
Article file
Get citation
 
 

Summary

Coronary artery anomalies are observed in approximately 2% of the population and have a high variability. Clinically they may be asymptomatic or there are anomalies that may lead to infarction or sudden death. Especially coronary artery anomalies such as origin from the pulmonary artery and interarterial course of coronary arteries of abnormal origin may cause sudden death. Multislice computed tomography, and coronary angiography can detect coronary artery anomalies with high sensitivity.

Introduction

The prevalence of coronary artery anomalies is rare in the population. In angiographic studies, the incidence ranges from 0.6% to 5.64% [1, 2], and, clinically, most patients are asymptomatic. Although the prognosis of coronary artery anomalies is generally good, some patients suffer from angina, dyspnea, syncope, ischemic heart disease, heart failure, ventricular arrhythmias, cerebrovascular accident, and even sudden death [36]. The latter is often associated with young individuals engaged in sporting activity [7].

Coronary anomalies (CAs) are mostly detected incidentally during autopsy, conventional coronary angiography (CCA) or through coronary computed tomography angiography (CCTA). While CCA is the gold standard technique for imaging coronary arteries, it is an invasive method, and imaging some complex CAs via CCA can be challenging. In such cases, CCTA is a more suitable method, especially in course anomalies [8].

Aim

This study evaluated follow-up data from a single tertiary care center to determine the prevalence of CAs and their effect on major cardiovascular events.

Material and methods

Between January 2015 and January 2023, 3095 consecutive patients who had undergone CCTA (age 18–90 years) were retrospectively enrolled. CCTA cases were excluded if they involved coronary artery disease (CAD), assessment of coronary artery grafts or stents, or evaluation of congenital heart disease. Exclusion criteria were: a history of allergies to iodinated contrast material, impaired renal function defined with an estimated glomerular filtration rate of < 45 ml/min/1.73 m2, diagnosed acute coronary syndrome, having been previously diagnosed with coronary artery anomalies, or pregnancy. As 78 patients were excluded from the study due to the inability to interpret images, the study included 3017 patients. The study is summarized in Figure 1.

Figure 1

Study flow chart

/f/fulltexts/PWKI/56695/PWKI-21-3-56695-g001_min.jpg

The classification method was used according to Angelini’s descriptions [9]. Myocardial bridges (MB) were excluded from the category of coronary anomalies because of the lack of clarity regarding their definition: some authors considered MB to be a normal variant, whereas others considered it to be an anomaly [1012]. Some types of CAs were represented in the central illustration of the study (Figure 2).

Figure 2

Central illustration of the study. The following schematic representation depicts the principal categories of anomalous coronary arteries. A – Anomalous origin from the opposite aortic sinus, B – coronary aneurysms, C – congenital atresia of LMCA, and D – anomalous origin from the pulmonary artery

AV – aortic valve, LAD – left anterior descending artery, LCC – left coronary cusp, LMCA – left main coronary artery, NCC – non-coronary cusp, PV – pulmonary valve, RCA – right coronary artery, RCC – right coronary cusp.

/f/fulltexts/PWKI/56695/PWKI-21-3-56695-g002_min.jpg

After CA had been determined, the patients were divided into two groups. Group 1 consisted of patients without CAs, while Group 2 consisted of patients with CAs. All patients were followed up, and follow-up symptom status was collected through a review of electronic medical records. Moreover, the results of cardiac testing were recorded via electronic medical records. Elective coronary intervention, acute coronary syndromes (ACS), and cerebrovascular events (CVE) were defined as major cardiovascular events (MACE).

Patients with significant coronary artery disease detected after CCTA underwent elective coronary angiography. According to the 2018 ESC/EACTS Guidelines on myocardial revascularization, the need for elective percutaneous coronary artery intervention was decided [13]. In patients who underwent elective coronary angiography due to clinical need during the follow-up period, elective percutaneous coronary artery intervention was performed, and was also defined as MACE. The mortality and MACE were recorded via the national medication report. Diagnosis of ACS was made according to the diagnostic criteria of the ESC for the management of ACS guidelines, published in 2023 [14]. CVE was defined as obstruction within a blood vessel supplying blood to the brain with imaging evidence, by either magnetic resonance imaging (MRI), or computed tomography (CT) scans, and a new neurologic deficit which lasted for at least 24 h [15].

Scan protocol and image acquisition

CCTA studies were performed using a 320-row CT scanner (Aquilion ONE, Toshiba Medical Systems, Otawara, Japan) with a gantry rotation time of 350 ms and a minimum temporal resolution of 175 ms. Metoprolol was administered orally (50–100 mg depending on heart rate) 1 h before CCTA acquisition to patients with a heart rate of > 65 beats per minute (bpm), unless contraindicated. The scanning technique was performed according to the patient’s heart rate.

Tube voltage and tube current depended on the body mass index (BMI) of the patients. Tube voltage was 100 kV (BMI < 23 kg/m2), 120 kV (BMI 23–34 kg/m2) or 135 kV (BMI > 35 kg/m2) and tube current was 320–580 mA. A total of 60–80 ml of non-ionic contrast agent (Iohexol, Omnipaque 350 mgI/ml, GE Healthcare Milwaukee, WI) was injected into the antecubital vein. A triphasic injection protocol of contrast agent was used. The initial step was for 50–70 ml of contrast agent to be injected at an injection rate of 5–6 ml/s, followed by 20 ml of 50% contrast/saline with the same injection rate. Subsequently, a saline chaser of 25 ml was injected at a flow rate of 3 ml/s. The scanning delay was determined with a bolus tracking technique by placing the region of interest (ROI) into the ascending aorta and setting the trigger threshold to 180 Hounsfield units (HU). All images were acquired during an inspiratory breath-hold of approximately 5 s. The raw data set was reconstructed at 75% of the R-R interval, with a slice thickness of 0.5 mm, and an interval of 0.25 mm, by using an iterative reconstruction algorithm. For processing and evaluation, images were transferred to a remote workstation with dedicated CCTA analysis software (Vitrea version 6.4, Vital Images, USA).

CCTA image analysis was performed by two radiologists in consensus, experienced in the assessment of CCTA. Data sets considered to be of poor image quality were excluded from this study.

Coronary arteries were assessed for atherosclerotic disease, anomalous origins, courses, and terminations. For the evaluation of coronary artery anomalies, all CCTA images were first reviewed in axial projection, then with different post-processing tools such as multiplanar reconstruction, curved multiplanar reconstruction, thin-slab maximum-intensity projection and volume rendered technique. Segments were classified according to the American Heart Association scheme [16].

Statistical analysis

The statistical analysis of data was conducted using IBM SPSS Statistics 22.0 for Windows, (IBM Corp, Armonk, NY, USA). Normality of data distribution was assessed using the Kolmogorov-Smirnov test. Data with a normal distribution were expressed as the mean ± standard deviation, while those with a non-normal distribution were expressed as the median (25–75% percentile). The Mann-Whitney U test and Student’s t-test were used to compare continuous variables. Categorical variables were shown as numbers and percentage values and were analyzed with the χ2 test. A survival plot of the effect of CAs on mortality and MACE in Group 2 was made by Kaplan-Meier analysis. A p-value of < 0.05 was considered statistically significant.

Results

This study consisted of 3017 patients, and 60 (2%) cases had CA among these patients (Group 2), with Group 1 consisting of 2957 patients. The median follow-up time was 56 months (28–76 months). The maximum follow-up time was 98 months and the minimum follow-up time was 2 months. Clinical and demographic parameters are summarized in Table I. The groups were similar in terms of history of chronic diseases such as cerebrovascular accident, congestive heart failure, coronary artery disease, diabetes mellitus, dyslipidemia, and, hypertension (respectively p = 0.68, 0.58, 0.96, 0.38, 0.89, and 0.98). Demographic characteristics such as gender, age, and smoking status were similar in both groups. (respectively p = 0.47, 0.58, and 0.38). The groups were compared in terms of clinical presentation, with syncope and palpitations found to be more common in Group 2 (p = 0.008 and 0.004 respectively). There were similar results in the groups for chest pain and dyspnea symptoms (respectively p = 0.36 and 0.92).

Table I

Demographic and clinical parameters of both groups

ParameterGroup 1 (n = 2957)Group 2 (n = 60)P-value
Age [years]51.55 ±12.8052.41 ±12.040.580
Gender (male)1636 (55.3%)34 (56.7%)0.472
Presenting symptom
 Chest pain2517 (85.2%)51 (87.9%)0.364
 Dyspnea256 (8.7%)6 (10%)0.927
 Syncope18 (0.6%)3 (5%)0.008
 Palpitation24 (8.2%)12 (20%)0.004
Risk factor
 Diabetes mellitus566 (19.2%)10 (16.7%)0.384
 Hypertension1316 (44.6%)27 (45%)0.988
 Dyslipidemia784 (27.1%)17 (29.8%)0.890
 Family history125 (4.2%)1 (1.7%)0.275
 Current smoker291 (9.9%)7 (11.8%)0.382
 Coronary artery disease268 (9.1%)6 (10%)0.961
 Congestive heart Failure70 (2.4%)1 (1.7%)0.584
 Cerebrovascular accident56 (1.9%)1 (1.7%)0.685
MACE
 Elective percutaneous intervention67 (2.3%)3 (5%)0.098
 Acute coronary syndrome30 (1%)0
 Cerebrovascular accident22 (0.7%)2 (3.3%)
 Mortality2 (0.1%)00.962

[i] AF – atrial fibrillation, MACE – major cardiovascular event, SVES – supraventricular ectopy, SVT – supraventricular tachycardia, VES – ventricular ectopy, VT – ventricular tachycardia.

Additionally, the groups were compared for mortality and MACE, and no difference was found between the groups (respectively p = 0.527 and 0.098). CVE and elective percutaneous procedures were more frequent in Group 2, but this frequency did not contribute to a significant difference between the groups in terms of MACE. Figures 3 A and B present the Kaplan-Meier analysis of MACE and mortality, respectively (log-rank = 0.516 and 0.206). Censored patients in the Kaplan-Meier analysis are those with unclear follow-up time.

Figure 3

A – Kaplan-Meier survival curve for mortality in both groups (log-rank p = 0.516), B – Kaplan Meier survival curve for major cardiovascular event-free survival rate in both groups (log-rank p = 0.206)

/f/fulltexts/PWKI/56695/PWKI-21-3-56695-g003_min.jpg

Origin anomalies were the most common abnormality, the coronary artery originating from the opposite coronary sinus. Right coronary artery (RCA) arising from the left coronary sinus (LCS) was the most common anomaly (21.7%). In second place was left main coronary artery (LMCA) (20%) atresia. These patients had no LMCA, a separate ostium of the left anterior descending coronary artery (LAD), and the left circumflex artery (LCX) from the LCS. The LMCA originated from the right sinus of Valsalva (RSV) in 1 (1.7%) case. In 4 patients, the left circumflex artery (LCX) arose from the RSV (6.7%) and the RCA (4 patients, 6.7%). Two (3.3%) patients had a single coronary artery, and 9 (15%) high-takeoff coronary arteries were determined. Sixteen (26.6%) patients had course anomalies, with coronary artery aneurysm being detected in 9 (15%) patients, and coronary artery fistulas in 3 (5%) patients. The results are summarized in Table II. Four patients were also found to have more than one anomaly.

Table II

Prevalence of coronary anomalies

Type of anomalyVariantSubvariantNumber of patientsAnomaly incidence among 3017 patients (%)Constituent ratio among 86 cases (%)
Anomalies of originAnomalous pulmonary origin of the coronariesOrigin of left main coronary artery from pulmonary artery11.5
Origin of right coronary artery from pulmonary artery0
Origin of circumflex coronary artery from pulmonary artery0
Origin of left and right coronary arteries from pulmonary artery0
Anomalous aortic origin of the coronariesOrigin of left main coronary artery from right aortic sinus of Valsalva11.7
Origin of right coronary artery from left aortic sinus of Valsalva130.421.7
Origin of left anterior descending coronary artery from right aortic sinus of Valsalva22.9
Origin of left anterior descending coronary artery from right coronary artery0
Origin of circumflex coronary artery from right aortic sinus of Valsalva40.16.7
Origin of circumflex coronary artery from right coronary artery40.16.7
Single coronary artery20.13.3
Inverted coronary arteries0
Origin of left main coronary artery from noncoronary aortic sinus of Valsalva11.7
Congenital atresia of the left main artery120.420
Anomaly of courseHigh take-off90.2915
Anomaly of osteal shape20.13.3
Anomaly of course80.2613
Coronary aneurysm90.2915
Anomaly of terminationCoronary arteriovenous fistula30.15

Figure 4 illustrates the tomographic images of a 46-year-old male patient who was subjected to an investigation for chest pain. It can be observed that the LMCA has its origin in the right coronary sinus.

Figure 4

Left main coronary artery arising from the right sinus of Valsalva with an interarterial course in a 46-year-old man. Axial (A) and volume rendering (B–D) CCTA images show left main coronary artery arising from the right sinus of Valsalva, coursing between aorta and pulmonary artery, dividing to left anterior descending and left circumflex arteries

Ao – aorta, LAD – left anterior descending artery, LCX – left circumflex artery, LMCA – left main coronary artery, PA – pulmonary artery, RCA – right coronary artery, RSV – right sinus of Valsalva.

/f/fulltexts/PWKI/56695/PWKI-21-3-56695-g004_min.jpg

Discussion

The prevalence of coronary artery anomalies in our series was 2%, and this finding is supported by previous studies [1, 2]. According to this study, results of MACE and mortality were similar in both groups. To the best of our knowledge, this is the first study to investigate the prevalence of coronary anomalies, determined via CCTA, and their effect on MACE and mortality in the literature of our country.

Conventional coronary angiography is the gold standard technique to diagnose and treat coronary artery disease. However, to understand some CAs, clinicians need additional diagnostic techniques. CCTA, a non-invasive test, can provide accurate information, especially course anomaly, termination of fistula, and relation of anomalous vessels to cardiac chambers and major arteries [17, 18].

The main cause of CAs remains unknown, and there is also no consistent definition in terms of gender and genetic transmission. There are 4 subgroups according to the Angelini classification [9]: origin, course, number, and termination anomalies of the coronary arteries. Origin anomalies, which are generally the most frequent, and anomalous origins of coronary arteries where the artery crosses over to the opposite sinus, show four course patterns: (1) an anterior course anterior to the pulmonary trunk or the right ventricular outflow tract, (2) an interarterial course between the pulmonary artery and the aorta, (3) a septal course through the interventricular septum, and (4) a retroaortic course posteriorly between the aortic root and the left atrium. The interarterial course between the pulmonary artery and the aorta is clinically significant because the compression of the coronary ostium may induce sudden death, myocardial ischemia, and congestive heart failure [10]. In the current study, the most common CAs were origin and course anomalies. Among origin anomalies, the most common was the RCA arising from the LSV (12, 20%). While 12 (92.3%) of 13 patients had an interarterial course, one of these cases was operated on and only one had a retroaortic course. The second most frequent anomaly determined in the study was atresia of the LMCA (12, 20%), and consisted of more than one ostium in the LSV. In the literature, the ranking of this anomaly is variable, and the prevalence of these CAs is 0.5–8% [19].

A single coronary artery is very rare in CAs, and is classified into 20 categories according to the location of this anomaly [20]. In this study, only 2 (3.3%) cases had a single coronary artery, both of which arose from the RSV and coursed to the anterior and right atrioventricular groove. In one study, it was suggested that the presence of a single coronary artery with an inter-arterial course may increase the risk of MACEs [21].

High takeoff of the coronary artery refers to it arising more than 0.5 cm above the sinotubular junction, rather than from the aortic sinus. This is a hemodynamically benign coronary anomaly and usually considered a normal variant, but it may cause technical difficulties [10]. In our study, the prevalence of high takeoff was 8.8%.

Coronary artery fistulas (CAf) are abnormal communications between a coronary artery and another structure such as a heart chamber, arteries, veins or the coronary sinus. The clinical situation varies according to the size of the CAf. Small CAf diagnoses incidentally occur during CA or CCTA, whereas large CAf causes steal syndrome and can lead to ischemia. CAfs are observed in 0.05–0.25% of patients undergoing conventional angiography. In this study, the prevalence of CAfs was 0.1% [22].

Myocardial ischemia is regarded as the principal underlying cause of life-threatening complications in patients with CAs. While some CAs (e.g., pulmonary origin of coronary arteries, coronary atresia) are invariably linked with severe impairment of myocardial perfusion, the relationship between other anomalies (e.g., anomalous aortic origin of coronaries) and myocardial ischemia is much more nuanced, with the clinical significance of these anomalies sometimes being more difficult to prove. Although provocative tests are recommended in cases where the etiology remains uncertain, the mechanisms linking some CAs to myocardial ischemia remain debatable. Furthermore, even in instances of myocardial ischemia, it remains unclear whether this is associated with an increased risk of life-threatening events [21]. The findings of our study lend support to this argument. The paucity of studies making such an assessment renders this finding particularly valuable.

In the current study, the MACE rate was not higher than in Group 2. Elective percutaneous intervention and cerebrovascular accident were more common in Group 2. However, these results did not affect the total. In a study by Musiani et al., it was found that congenital atresia of the left main coronary artery was associated with congestive heart failure or malignant arrhythmias during infancy in most cases [23]. Additionally, in a meta-analysis including 5486 subjects with MB, it was found that MB was associated with a higher risk of myocardial infarction. However, the same results were not observed in other MACE [24]. Conversely, a report pooling 21 studies showed that, although MACE and myocardial ischemia were more common in patients with myocardial bridging, no significant differences emerged when myocardial infarction and cardiovascular death were considered endpoints [25].

The latest 2018 American College of Cardiology/American Heart Association guidelines for the management of adults with congenital heart disease recommend that all patients exhibiting symptoms or evidence of ischemia during diagnostic testing should undergo repair (Class I). However, for patients with left anomalous aortic origin of a coronary artery (AAOCA), or those who do not meet this criteria, surgical intervention is now only a Class IIa recommendation, which decreases to IIb in right AAOCA, unless patients present with ventricular arrhythmias [26]. The recommendations of the 2020 adult congenital heart disease guideline of the European Society of Cardiology are similar [27]. In both guidelines, all recommendations are based on the demonstration of ischemia and individualization of treatment. However, the surgery is the first-line treatment choice according to guidelines. In the study of Mainwaring et al. including 115 subjects, 97% exhibited no symptoms during the follow-up period, and no deaths were documented, either perioperatively or postoperatively [28]. Moreover, a systematic review of surgically corrected left coronary artery originating from the right aortic sinus (n = 325) revealed a low mortality rate (0.9%), and only 2.2% of patients exhibited symptoms at the last follow-up [29]. Nevertheless, there is no evidence that surgery reduces SCD in these patients. The lack of controlled studies and long-term follow-up data means that the true risk-to-benefit ratio of surgery is currently unknown. Furthermore, although anatomic clues historically associated with SCD should not be overlooked, it is imperative to demonstrate a causal link between CAs and myocardial ischemia before surgery is indicated. Indeed, in a study including 24 patients with such CAs, subclinical signs of inducible ischemia persisted even after surgical correction, which highlights the necessity for caution against unwarranted surgical intervention.

There are two separate studies in the literature in which patients with CAs were medically followed up. A study consisting of 56 adults, who were managed conservatively with exercise restriction or medical therapy (namely β-blockers, calcium channel blockers, nitrates, and antiarrhythmic drugs), observed no cases of sudden cardiac death at a mean follow-up of 5.6 years [30]. In contrast to the findings of this study, Opolski et al. reported that 19 out of 70 (27%) patients who underwent medical management reported exacerbation of chest pain, or a reduction in exercise tolerance, at a mean follow-up period of 1.3 years [31]. This was particularly prevalent in individuals with an interarterial course. In our study, only 1 patient was operated on and the other patients were followed up.

The study did have some limitations. The first was that it was single-centered and retrospective. Therefore, some important clinical characteristics of the patients included in this study were not documented due to its retrospective nature. Moreover, the national death notification system is not connected with the hospital medical record system. Therefore, patients whose medication reports had not been renewed after the last day of medication reports were accepted as having died. Patients who had not been prescribed via the national medical system in the previous year were accepted as being dead. In addition, minor CAs, such as coronary artery ectasia and MB artery, were excluded.

Conclusions

The prevalence of coronary anomalies in the present study was 2%. Anomalies of origin and course in the current study were the most common, and follow-up results were consistent with previous studies.

Ethical approval

The study was approved by the Institutional Review Board of our institution on 21 February 2023 (no: 2023.02-15) according to several regulations, including the Declaration of Helsinki.

Conflict of interest

The authors declare no conflict of interest.

References

1 

Kashyap JR, Kumar S, Reddy S, et al. Prevalence and pattern of congenital coronary artery anomalies in patients undergoing coronary angiography at a Tertiary Care Hospital of Northern India. Cureus 2021; 10: e14399.

2 

Muhtaroglu M, Lafci Fahrioglu S, Beton O, İlgi S. Is the prevalence of coronary artery anomalies different in countries with small populations? A retrospective study in Northern Cyprus. Heart Surg Forum 2021; 24: E1027–32.

3 

Bigler MR, Kadner A, Raeber L, et al. Therapeutic management of anomalous coronary arteries originating from the opposite sinus of Valsalva: current evidence, proposed approach, and the unknowing. J Am Heart Assoc 2022; 11: e027098.

4 

Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC). Eur Heart J 2021; 42: 17–96.

5 

Sessa F, Esposito M, Messina G, et al. Sudden death in adults: a practical flow chart for pathologist guidance. Healthcare 2021; 9: 870.

6 

Usalp S, Dereli Bulut SS, Çelebi F, Altuntaş E. Paradoxical cerebral and coronary embolism in a young patient due to right atrial appendage aneurysm: a case report. Turk Kardiyol Dern Ars 2025 doi: 10.5543/tkda.2024.36737.

7 

D’Ascenzi F, Valentini F, Pistoresi S, et al. Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: sudden cardiac death in the young. Trends Cardiovasc Med 2022; 32: 299–308.

8 

Hołda MK. Back to basics: do interventional cardiologists have to relearn anatomy? Adv Interv Cardiol 2024; 20: 121–3.

9 

Angelini P. Coronary artery anomalies: an entity in search of an identity. Circulation 2007; 115: 1296–305.

10 

Namgung J, Kim JA. The prevalence of coronary anomalies in a single center of Korea: origination, course, and termination anomalies of aberrant coronary arteries detected by ECGgated cardiac MDCT. BMC Cardiovasc Disord 2014; 14: 48.

11 

Sternheim D, Power DA, Samtani R, et al. Myocardial bridging: diagnosis, functional assessment, and management: JACC state-of-the-art review. J Am Coll Cardiol 2021; 78: 2196–212.

12 

Kim PJ, Hur G, Kim SY, et al. Frequency of myocardial bridges and dynamic compression of epicardial coronary arteries: a comparison between computed tomography and invasive coronary angiography. Circulation 2009; 119: 1408–16.

13 

Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87–165.

14 

Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44: 3720–826.

15 

Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52: e364–467.

16 

Habets J, van den Brink RBA, Uijlings R, et al. Coronary artery assessment by multidetector computed tomography in patients with prosthetic heart valves. Europ Radiol 2012; 22: 1278–86.

17 

John J, Miller JH, Leslie SJ. A case of anomalous coronary artery origin: the role of computerised tomography. SAGE Open Med Case Rep 2016; 4: 2050313X16628729.

18 

Aziz, MU, Singh SP. Coronary artery anomalies evaluation with cardiac computed tomography: a review. J Med Imaging Radiat Sci 2021; 52: S40–50.

19 

Graidis C, Dimitriadis D, Karasavvidis V, et al. Prevalence and characteristics of coronary artery anomalies in an adult population undergoing multidetector-row computed tomography for the evaluation of coronary artery disease. BMC Cardiovasc Disord 2015; 15: 112.

20 

Bruna-Mejias A, del Villar-Valdebenito J, Roman C, et al. Hypoplastic and congenital absence of coronary arteries and its correlation with clinical implications of cardiac circulation: a systematic review and meta-analysis. J Clin Med 2024; 13: 3085.

21 

Gentile F, Castiglione V, De Caterina R. Coronary artery anomalies. Circulation 2021; 144: 983–96.

22 

Al-Umairi RS, Al-Kindi F, Al-Tai S. Prevalence and spectrum of coronary anomalies detected on coronary computed tomography angiography a single centre experience in OmanSultan. Qaboos Univ Med J 2019; 19: e108–13.

23 

Tsuda E, Yagihara T, Tsukano S, et al. Characteristics and long-term outcome for congenital left main coronary artery atresia. Cardiol Young 2023; 33: 383–7.

24 

Hong L, Liu J, Luo S, Li J. Relation of myocardial bridge to myocardial infarction: a meta-analysis. Chin Med J 2014; 27: 945–50.

25 

Hostiuc S, Rusu MC, Hostiuc M, et al. Cardiovascular consequences of myocardial bridging: a meta-analysis and meta-regression. Sci Rep 2017; 7: 14644.

26 

Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2018; 139: e698–800.

27 

Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2020; 42: 563–645.

28 

Mainwaring RD, Murphy DJ, Rogers IS, et al. Surgical repair of 115 patients with anomalous aortic origin of a coronary artery from a single institution. World J Pediatr Congenit Heart Surg 2016; 7: 353–9.

29 

Nguyen AL, Haas F, Evens J, Breur JM. Sudden cardiac death after repair of anomalous origin of left coronary artery from right sinus of Valsalva with an interarterial course: case report and review of the literature. Neth Heart J 2012; 20: 463–71.

30 

Kaku B, Shimizu M, Yoshio H, et al. Clinical features of prognosis of Japanese patients with anomalous origin of the coronary artery. Jpn Circ J 1996; 60: 731–41.

31 

Opolski MP, Pregowski J, Kruk M, et al. Prevalence and characteristics of coronary anomalies originating from the opposite sinus of Valsalva in 8,522 patients referred for coronary computed tomography angiography. Am J Cardiol 2013; 111: 1361–7.

Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.